The changing face of HIV-associated lymphoma: what can we learn about optimal therapy inl the post highly active antiretroviral therapy era? (Q36180864)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The changing face of HIV-associated lymphoma: what can we learn about optimal therapy inl the post highly active antiretroviral therapy era?	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

1 reference

Europe PubMed Central

The changing face of HIV-associated lymphoma: what can we learn about optimal therapy inl the post highly active antiretroviral therapy era? (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

author name string

Alison Clayton

1

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Tariq Mughal

2

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Hematological Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

111-120

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Spectrum of AIDS-associated malignant disorders

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing incidence of cancers associated with the human immunodeficiency virus epidemic

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival.

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effect of highly active antiretroviral therapy on the prognosis of AIDS-related systemic non-Hodgkin lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494).

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of AIDS-related non-Hodgkin's lymphoma with chemotherapy (CNOP) and r-hu-G-CSF: clinical outcome and effect on HIV-1 viral load

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokines alter production of HIV-1 from primary mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic interaction between chemotherapy for non-Hodgkin's lymphoma and protease inhibitors in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem cell transplantation for HIV-associated lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Infusional CDE with rituximab for the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: preliminary results of a phase I/II study

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials.

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-associated lymphoma: promising new results, but with toxicity

1 reference

https://api.crossref.org/works/10.1002%2FHON.735

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HON.735

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36180864&oldid=1979838472"